Mirabegron

Mirabegron

Mirabegron is a pharmaceutical drug, indicated for the effective treatment of overactive bladder. It leads to muscle relaxation and an increase in bladder capacity by activating Ã23 adrenergic receptor present in the detrusor muscle of bladder. Recently, this drug has shown its efficacy in activating brown fat and increase in metabolism. Based on a small study, this drug is proved to exhibit the ability of increasing metabolic rate, basal heart rate and blood pressure that are major signs of cardiovascular stimulation.

29676-71-9:

Mirabegron

66659-20-9:

Mirabegron

29968-78-3:

Mirabegron

521284-21-9:

Mirabegron

391901-45-5:

Mirabegron

521284-22-0:

Mirabegron

53266-94-7:

Mirabegron

223673-35-6:

Mirabegron

Specifications :

Intermediate CAS No API/End Use Status Purity
Ethyl 2-(2-aminothiazol-4-yl)acetate 53266-94-7 Mirabegron Commercial
2-(2-Aminothiazol-4-yl)acetic acid 29676-71-9 Mirabegron Commercial 100%
2-(2-Aminothiazol-4-yl)acetic acid hydrochloride 66659-20-9 Mirabegron Commercial 99.94%
2-(4-nitrophenyl)ethanamine hydrochloride 29968-78-3 Mirabegron Commercial 99.96%
(R)-2-(4-nitrophenethylamino)-1-phenylethanol hydrochloride 521284-21-9 Mirabegron lab Scale 99.55%
(R)-4-nitro phenethylamino-(2-hydroxy-2-phenylethyl)-tert-butyl carbamate 223673-35-6 Mirabegron lab Scale
(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol 391901-45-5 Mirabegron Pilot Scale
(R)-2-((4-Aminophenethyl)amino)-1-phenylethanol HCL 521284-22-0 Mirabegron Pilot Scale 99.12%